Is Sugar The New Tobacco?
In our Outlook on Obesity blog series, we’re looking at some of the key issues, trends and interventions related to obesity, alongside the risks this growing problem presents for insurers.
Cutaneous Malignant Melanoma: The Science Behind The Guidelines
For decades the frequency of cutaneous melanomas worldwide has been increasing faster than any other cancer. Melanomas cause about 90 percent of skin cancer mortality.
Why The Insurance Industry Should Invest In Technology - And Now
Here’s a scary thought: Many insurance companies are still using technology created decades ago — and for critical functions. Carriers are able to get necessary work accomplished, but are well behind other industries in terms of providing the level of service that customers increasingly demand in 2015.
A Crossroad Awaits in India
In the 15 years since India reprivatised its insurance industry, several models have been developed to optimise operations, distribution, and suitability. Mr. Amit Punchhi of RGA examines the three elements that are contributing to the slowing down of the life market’s growth.
Higher Mortality Risk in Individuals with Mental Health Disorders
Individuals with mental health disorders have a risk of mortality that is two times higher than the general population or than individuals without such disorders, according to a new study.
MIB Life Index Reports U.S. Life Insurance Activity up +5.7% in January
Application activity for individually underwritten life insurance increased +5.7% in January, year-over-year, all ages combined, according to the MIB Life Index.
Life Underwriting in 2020
I am neither a clairvoyant nor in possession of a crystal ball. This confessed, after 45 years in life insurance risk assessment - and with an obsessive focus on tracking trends - I have some reasonably credible thoughts regarding how underwriting will be configured five years hence.
When Is Screening Essential?
The proper assessment of current health is essential for underwriters to come to the best (and hopefully most aggressive) decision on policy pricing. This is straightforward when tests and current assessment of well being have been done by an attending physician and favorable results lead to standard and preferred issues. What about screening tests for health that assess risk and allow both the doctor and patient/insured to look for disease that isn’t currently causing symptoms?